JP Morgan Chase’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.41M | Buy |
112,954
+6,466
| +6% | +$165K | ﹤0.01% | 3966 |
|
|
2025
Q4 | $3.09M | Buy |
106,488
+5,694
| +6% | +$146K | ﹤0.01% | 3736 |
|
|
2025
Q3 | $1.9M | Sell |
100,794
-447,995
| -82% | -$7.07M | ﹤0.01% | 4123 |
|
|
2025
Q2 | $7.69M | Buy |
548,789
+5,407
| +1% | +$75.8K | ﹤0.01% | 2773 |
|
|
2025
Q1 | $8.5M | Sell |
543,382
-598,123
| -52% | -$8.43M | ﹤0.01% | 2689 |
|
|
2024
Q4 | $15.9M | Sell |
1,141,505
-155,406
| -12% | -$1.7M | ﹤0.01% | 2248 |
|
|
2024
Q3 | $12.1M | Buy |
1,296,911
+11,833
| +0.9% | +$117K | ﹤0.01% | 2450 |
|
|
2024
Q2 | $12M | Buy |
1,285,078
+284,872
| +28% | +$2.58M | ﹤0.01% | 2296 |
|
|
2024
Q1 | $9.91M | Buy |
1,000,206
+928,741
| +1,300% | +$6.93M | ﹤0.01% | 2498 |
|
|
2023
Q4 | $231K | Sell |
71,465
-7,246
| -9% | -$19.7K | ﹤0.01% | 5309 |
|
|
2023
Q3 | $418K | Buy |
78,711
+7,703
| +11% | +$65.5K | ﹤0.01% | 4582 |
|
|
2023
Q2 | $677K | Buy |
71,008
+15,969
| +29% | +$177K | ﹤0.01% | 4312 |
|
|
2023
Q1 | $605K | Buy |
55,039
+10,431
| +23% | +$151K | ﹤0.01% | 4371 |
|
|
2022
Q4 | $660K | Buy |
44,608
+1,062
| +2% | +$18.6K | ﹤0.01% | 4337 |
|
|
2022
Q3 | $833K | Buy |
43,546
+10,434
| +32% | +$236K | ﹤0.01% | 4140 |
|
|
2022
Q2 | $706K | Buy |
33,112
+6,090
| +23% | +$125K | ﹤0.01% | 4339 |
|
|
2022
Q1 | $520K | Buy |
27,022
+4,646
| +21% | +$78.6K | ﹤0.01% | 4673 |
|
|
2021
Q4 | $464K | Buy |
22,376
+2,080
| +10% | +$41.4K | ﹤0.01% | 4885 |
|
|
2021
Q3 | $484K | Buy |
20,296
+862
| +4% | +$19.7K | ﹤0.01% | 4749 |
|
|
2021
Q2 | $531K | Buy |
19,434
+4,582
| +31% | +$129K | ﹤0.01% | 4654 |
|
|
2021
Q1 | $430K | Buy |
14,852
+5,527
| +59% | +$173K | ﹤0.01% | 4767 |
|
|
2020
Q4 | $262K | Buy |
9,325
+2,586
| +38% | +$63.3K | ﹤0.01% | 4708 |
|
|
2020
Q3 | $209K | Buy |
6,739
+3,540
| +111% | +$94.6K | ﹤0.01% | 4342 |
|
|
2020
Q2 | $96K | Sell |
3,199
-152
| -5% | -$4.39K | ﹤0.01% | 4589 |
|
|
2020
Q1 | $100K | Buy |
+3,351
| New | +$90K | ﹤0.01% | 4510 |
|
Other funds holding ARQT
SCM
FLSM
RCMNY
PCH
VCM
GGHC
